ArticleNature2022
Researchers fear growing COVID vaccine hesitancy in developing nations.
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Occupational health and safety in the wake of COVID-19: insights from India's workforce.Frontiers in public health · 2026Pooled it
- Pooled it
- Trends in childhood routine immunisation and maternal health service access and utilisation in Sokoto State, Nigeria. A quantitative survey.Scientific reports · 2025Article
- Article
- COVID-19 booster dose vaccination of healthcare workers in Qatar: A web-based cross-sectional survey.Public health challenges · 2023Article
- Recent trends in vaccine coverage and confidence: A cause for concern.Human vaccines & immunotherapeutics · 2023Article
- Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost.iScience · 2023Article
- The association between vaccination status identification and societal polarization.Nature human behaviour · 2023Article
- Proposing a New Conceptual Syndemic Framework for COVID-19 Vaccine Hesitancy: A Narrative Review.International journal of environmental research and public health · 2023Review
- Article
- Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy.Pharmacy (Basel, Switzerland) · 2022Article
- Current clinical status of new COVID-19 vaccines and immunotherapy.Environmental science and pollution research international · 2022Review
- COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.Infectious diseases and therapy · 2022Article
- Explaining vaccine hesitancy: A COVID-19 study of the United States.Managerial and decision economics : MDE · 2022Article
- Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control.Vaccines · 2022Review
- COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria.Vaccines · 2022Article
- Review
- It is not too late to achieve global covid-19 vaccine equity.BMJ (Clinical research ed.) · 2022Article
- Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.PloS one · 2022Article
- An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant.PloS one · 2022Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34949861What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.